Page last updated: 2024-11-06

ci 18055

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acid violet 7: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61349
SCHEMBL ID1462889
MeSH IDM0548811

Synonyms (84)

Synonym
cetil light red 6b
red 6b
metamine acid fuchsine 6b
4321-69-1
nsc-8669
lissamine red 6b
acilan naphthol red 6b
acid naftol red 6b
acid violet 7
naphtocard red 6b
calcocid fuchsine 6b
amido red 6b
unitertracid red 6b
hexalan red 6b
acilan naphtol red 6b
bucacid fast crimson 6b
1425 red
acetyl rose 5bl
java naphtol red 6b
brilliant acid red 6a
solar fast red 6b
brilliant acid rosamine 6b
c.i. acid violet 7, disodium salt
egacid red 6b
curol red 6b
amido naphthol red 2b
azo rhodine 6b
acid rose 6bl
hidacid fast fuchsine 6b
acetyl rose 6bl
amacid fuchsine 6b
fenazo fuchsine 6b
brilliant colacid red 6a
hispacid fast carmoisine 6b
azo naphthol red 6b
kiton red 7b
amido naphthol red 6b
fast crimson 6bl (biological stain)
erio floxine 6b
atul acid geranine 6b
acid red 6b
azo fuchsine 6b
c.i. food red 11
c.i. 18055
pontacyl carmine 6b
hexacol red 6b
acetyl red 6b
c.i. acid violet 7
diacid fast red 6b
eniacid light red 6b
erio floxine 6bn
vondacid naphthol red 6b
acidine red 6b
ext d and c red no. 1
kiton red 6b
einecs 224-352-1
2,7-naphthalenedisulfonic acid, 5-(acetylamino)-3-((4-(acetylamino)phenyl)azo)-4-hydroxy-, disodium salt
czerwien kwasowa trwala e6b [polish]
fast crimson 6bl
acid fast red e 6b
2,7-naphthalenedisulfonic acid, 5-(acetylamino)-3-((4-(acetylamino)phenyl) azo)-4-hydroxy-, disodium salt
kiton red 6b-fq
disodium 5-acetamido-3-(4-acetamidophenyl)azo-4-hydroxynaphthalene-2,7-disulphonate
nsc 8669
acid leather red k 6b
acid violet 7, dye content 40 %
AKOS000282963
SCHEMBL1462889
AKOS024319599
w626x6moe1 ,
ci-18055
ci 18055
2,7-naphthalenedisulfonic acid, 5-(acetylamino)-3-(2-(4-(acetylamino)phenyl)diazenyl)-4-hydroxy-, sodium salt (1:2)
ci18055
unii-w626x6moe1
czerwien kwasowa trwala e6b
j8.707f ,
disodium 5-acetamido-3-(4-acetamidophenyl)azo-4- hydroxynaphthalene-2,7-disulphonate
DTXSID8044672
sodium (e)-5-acetamido-3-((4-acetamidophenyl)diazenyl)-4-hydroxynaphthalene-2,7-disulfonate
UNEOZSZVJMTZBX-YCQUHOTGSA-L
Q27292365
disodium;5-acetamido-3-[(4-acetamidophenyl)diazenyl]-4-hydroxynaphthalene-2,7-disulfonate
5-(acetylamino)-3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-2,7-naphthalenedisulfonic acid disodium salt
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.08 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]